Inventor · disambiguated record
Nicholas Keen
Also filed as: KEEN NICHOLAS JOHN · KEEN Nicholas
8 granted patents·15 pending applications·131 citations·filing 2000–2024
87Inventor score
Top patents by PatentIndex Score
23 records- 0195US11453703B2Heterotandem bicyclic peptide complexesBICYCLETX LTD·Filed 2019·Granted Sep 27, 2022·15 cites·17 claims
- 0293US11613560B2Bicyclic peptide ligands specific for OX40BICYCLETX LTD·Filed 2020·Granted Mar 28, 2023·15 cites·26 claims
- 0390US7081461B1Quinazoline compounds and pharmaceutical compositions containing themASTRAZENECA AB·Filed 2000·Granted Jul 25, 2006·48 cites·8 claims
- 0489US12459974B2Bicyclic peptide ligands specific for Nectin-4BICYCLETX LTD·Filed 2024·Granted Nov 4, 2025·0 cites·11 claims
- 0584US2025263438A9Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 0684US2025051392A1Bicyclic peptide ligands specific for nectin-4BICYCLETX LTD·Filed 2024·Application pending·0 cites
- 0783US7709479B1Quinazoline derivatives and their use as pharmaceuticalsASTRAZENECA·Filed 2000·Granted May 4, 2010·19 cites·3 claims
- 0878US7235559B1Therapeutic quinazoline derivativesASTRAZENECA AB·Filed 2000·Granted Jun 26, 2007·15 cites·14 claims
- 0974US7214518B2Crystal structure of aurora a kinase and uses thereofASTRAZENECA AB·Filed 2002·Granted May 8, 2007·12 cites·3 claims
- 1073US7105669B1Quinazoline derivativesASTRAZENECA AB·Filed 2000·Granted Sep 12, 2006·7 cites·18 claims
- 1167US2023008076A1Heterotandem bicyclic peptide complexesBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 1258US2024091368A1Anti-infective bicyclic peptide ligandsBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 1357US2025186539A2Methods for treating cancerBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 1456US2009253616A1Combination therapy for the treatment of cancerASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1555US2024108737A1Anti-infective bicyclic peptide ligandsBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 1654US2024083945A1Anti-infective bicyclic peptide ligandsBICYCLETX LTD·Filed 2022·Application pending·0 cites
- 1749US2020291096A1Bicyclic peptide ligand sting conjugates and uses thereofBICYCLERD LTD·Filed 2018·Application pending·0 cites
- 1848US2025325672A1Anti-infective bicyclic peptide ligandsBICYCLE TX LTD·Filed 2022·Application pending·0 cites
- 1948US2024083944A1Anti-infective bicyclic peptide ligandsBICYCLE TX LTD·Filed 2022·Application pending·0 cites
- 2047US2024108738A1Bicyclic peptide ligands specific for nk cellsBICYCLE TX LTD·Filed 2022·Application pending·0 cites
- 2146US2024197897A1Heterotandem bicyclic peptide complexesBICYCLE TX LTD·Filed 2022·Application pending·0 cites
- 2243US2023183291A1Anti-infective bicyclic peptide ligandsBICYCLE TX LTD·Filed 2021·Application pending·0 cites
- 2343US2020283482A1Bicyclic peptide ligand prr-a conjugates and uses thereofBICYCLERD LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas Keen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →